Detalhe da pesquisa
1.
Ibrutinib in mantle cell lymphoma: a real-world retrospective multi-center analysis of 77 patients treated in the Czech Republic.
Ann Hematol
; 102(1): 107-115, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36369497
2.
Complex genetic and histopathological study of 15 patient-derived xenografts of aggressive lymphomas.
Lab Invest
; 102(9): 957-965, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35488033
3.
A high TP53 mutation burden is a strong predictor of primary refractory mantle cell lymphoma.
Br J Haematol
; 191(5): e103-e106, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32862455
4.
Experimental model of primary intraocular lymphoma based on BALB/CaNn strain and A20 cells is optimal for investigational research.
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub
; 2024 Feb 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38410917
5.
Cyclin dependent kinase 4/6 inhibitor palbociclib synergizes with BCL2 inhibitor venetoclax in experimental models of mantle cell lymphoma without RB1 deletion.
Exp Hematol Oncol
; 13(1): 34, 2024 Mar 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38528594
6.
Concurrent TP53 and CDKN2A Gene Aberrations in Newly Diagnosed Mantle Cell Lymphoma Correlate with Chemoresistance and Call for Innovative Upfront Therapy.
Cancers (Basel)
; 12(8)2020 Jul 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-32751805